Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Current Obstetrics and Gynecology Reports
Erschienen in: Current Obstetrics and Gynecology Reports 2/2018

21.04.2018 | Minimally Invasive Gynecologic Surgery (A Yunker, Section Editor)

Hemostasis Techniques in Myomectomies

verfasst von: Kelly Wright, Michelle Louie, Matthew Siedhoff

Erschienen in: Current Obstetrics and Gynecology Reports | Ausgabe 2/2018

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

Myomectomy can be associated with significant blood loss, particularly when large and numerous fibroids are removed. Surgeons have incorporated a large number of methods to reduce blood loss, including pre-operative optimization, the use of minimally invasive surgery, and intraoperative techniques. The purpose of this review is to summarize these methods and evaluate the literature supporting those with clinical value.

Recent Findings

The use of minimally invasive surgery has clear benefit in reducing blood loss in myomectomy for appropriately selected patients. Preoperative hormonal treatments reduce myoma size and reduce the complexity of myomectomy. Myometrial vasoconstriction, vessel ligation or compression, and the use of barbed suture decrease blood loss in myomectomy.

Summary

Surgeons should be aware of the large number of pre-operative and intraoperative measures to reduce blood loss in myomectomy and employ those with proven clinical benefit, particularly in operations that are likely to involve excessive bleeding and the need for transfusion.
Literatur
1.
•• Hickman LC, Kotlyar A, Shue S, Falcone T. Hemostatic techniques for myomectomy: an evidence-based approach. J Minim Invasive Gynecol. 2016;23(4):497–504. This article provides a practical, comprehensive summary of various techniques used to reduce blood loss in laparoscopic and laparotomic myomectomy. CrossRefPubMed
2.
•• Bhave Chittawar P, Franik S, Pouwer AW, Farquhar C. Minimally invasive surgical techniques versus open myomectomy for uterine fibroids. Cochrane Database Syst Rev. 2014;(10):CD004638. https://​doi.​org/​10.​1002/​14651858.​CD004638.​pub3. This Cochrane review included nine randomized trials and concluded that laparoscopic myomectomy resulted in decreased post-operative pain, fever, hospital stay, with no difference in fibroid recurrence, compared to laparotomy.
3.
Cardozo ER, Clark AD, Banks NK, Henne MB, Stegmann BJ, Segars JH. The estimated annual cost of uterine leiomyomata in the United States. Am J Obstet Gynecol. 2012;206(3):211.e1–9.CrossRef
4.
Buckley VA, Nesbitt-Hawes EM, Atkinson P, Won HR, Deans R, Burton A, et al. Laparoscopic myomectomy: clinical outcomes and comparative evidence. J Minim Invasive Gynecol. 2015;22(1):11–25.
5.
Barakat EE, Bedaiwy MA, Zimberg S, Nutter B, Nosseir M, Falcone T. Robotic-assisted laparoscopic, and abdominal myomectomy: a comparison of surgical outcomes. Obstet Gynecol. 2011;117(2 Pt 1):256–65.CrossRefPubMed
6.
• Frascà C, Tuzzato G, Arena A, Degli Esposti E, Zanello M, Raimondo D, Seracchioli R. The Role of Pelvic Ultrasound in Preoperative Evaluation for Laparoscopic Myomectomy. J Minim Invasive Gynecol. 2017. https://​doi.​org/​10.​1016/​j.​jmig.​2017.​08.​661. One-hundred twenty-five women were consecutively examined with ultrasound prior to laparosocpic myomectomy. Five percent of myomas were not detected at the time of laparoscopy, the majority of which were small (< 2cm) FIGO type 3 and 4.
7.
Fambrini M, Tondi F, Scarselli G, Penna C, Pieralli A, Andersson KL, et al. Comparison of the number of uterine myomas detected by in-office transvaginal ultrasonography removed by laparotomic myomectomy: preoperative work-up concerns. Clin Exp Obstet Gynecol. 2009;36(2):97–101.
8.
ACOG committee opinion no. 557: Management of acute abnormal uterine bleeding in nonpregnant reproductive-aged women. Obstet Gynecol. 2013;121(4):891–6.
9.
•• Hossain MZ, Rahman MM, Ullah MM, Mukthadira M, Akter FA, Jahan AB, et al. A comparative study of magnetic resonance imaging and transabdominal ultrasonography for the diagnosis and evaluation of uterine fibroids. Mymensingh Med J. 2017;26(4):821–7. Forty patients were examined consecutively with ultrasound and MRI before myomectomy. MRI outperformed ultrasound on all fronts—sensitivity, specificity, accuracy, positive predictive value, and negative predictive value. PubMed
10.
Munro MG, Critchley HO, Broder MS, Fraser IS. FIGO classification system (PALM-COEIN) for causes of abnormal uterine bleeding in nongravid women of reproductive age. Int J Gynaecol Obstet. 2011;113(1):3–13.CrossRefPubMed
11.
Jin C, Hu Y, Chen XC, Zheng FY, Lin F, Zhou K, et al. Laparoscopic versus open myomectomy—a meta-analysis of randomized controlled trials. Eur J Obstet Gynecol Reprod Biol. 2009;145(1):14–21.
12.
• Vargas MV, Moawad GN, Sievers C, Opoku-Anane J, Marfori CQ, Tyan P, et al. Feasibility, safety, and prediction of complications for minimally invasive myomectomy in women with large and numerous myomata. J Minim Invasive Gynecol. 2017;24(2):315–22. This retrospective study examined 221 women who underwent laparoscopic (conventional or robotic) myomectomy. Nine percent experienced excessive blood loss, 4% transfusion, and 2% conversion to laparotomy. Fibroid size greater than 12 cm and uterine volume greater than 750 mL were predictive of complications. CrossRefPubMed
13.
Sinha R, Hegde A, Mahajan C, Dubey N, Sundaram M. Laparoscopic myomectomy: do size, number, and location of the myomas form limiting factors for laparoscopic myomectomy? J Minim Invasive Gynecol. 2008;15(3):292–300.CrossRefPubMed
14.
Peyrin-Biroulet L, Williet N, Cacoub P. Guidelines on the diagnosis and treatment of iron deficiency across indications: a systematic review. Am J Clin Nutr. 2015;102(6):1585–94.CrossRefPubMed
15.
Stoffel NU, Cercamondi CI, Brittenham G, Zeder C, Geurts-Moespot AJ, Swinkels DW, et al. Iron absorption from oral iron supplements given on consecutive versus alternate days and as single morning doses versus twice-daily split dosing in iron-depleted women: two open-label, randomised controlled trials. Lancet Haematol. 2017;4(11):e524–e33.CrossRefPubMed
16.
Auerbach M, Schrier S. Treatment of iron deficiency is getting trendy. Lancet Haematol. 2017;4(11):e500–e1.CrossRefPubMed
17.
Matteson KA, Abed H, Wheeler TL 2nd, Sung VW, Rahn DD, Schaffer JI, et al. A systematic review comparing hysterectomy with less-invasive treatments for abnormal uterine bleeding. J Minim Invasive Gynecol. 2012;19(1):13–28.CrossRefPubMed
18.
•• Lethaby A, Puscasiu L, Vollenhoven B. Preoperative medical therapy before surgery for uterine fibroids. Cochrane Database Syst Rev. 2017;11:Cd000547. This updated Cochrane review included 38 randomized trials and concluded benefits of both GnRHa and ulipristal pre-treatment before surgery for fibroids. These measures decrease uterine size and reduce blood loss and operative time. PubMed
19.
• de Milliano I, Twisk M, Ket JC, Huirne JA, Hehenkamp WJ. Pre-treatment with GnRHa or ulipristal acetate prior to laparoscopic and laparotomic myomectomy: a systematic review and meta-analysis. PLoS One. 2017;12(10):e0186158. This systematic review included 23 studies and concluded that GnRHa decrease blood loss and the need for transfusion during myomectomy but there was insufficient evidence to make similar conclusions for ulipristal. CrossRefPubMedPubMedCentral
20.
Chen I, Motan T, Kiddoo D. Gonadotropin-releasing hormone agonist in laparoscopic myomectomy: systematic review and meta-analysis of randomized controlled trials. J Minim Invasive Gynecol. 2011;18(3):303–9.CrossRefPubMed
21.
22.
Ghiaroni J, Lopez GE, Coutinho Junior AC, Schanaider A. Uterine artery embolization with spherical PVA-PVAc particles as preparation for surgical resection of myomas. Rev Col Bras Cir. 2013;40(5):386–91.CrossRefPubMed
23.
Frederick J, Fletcher H, Simeon D, Mullings A, Hardie M. Intramyometrial vasopressin as a haemostatic agent during myomectomy. Br J Obstet Gynaecol. 1994;101(5):435–7.CrossRefPubMed
24.
Assaf A. Adhesions after laparoscopic myomectomy: effect of the technique used. Gynaecol Endosc. 1999;8:225–9.CrossRef
25.
Zhao F, Jiao Y, Guo Z, Hou R, Wang M. Evaluation of loop ligation of larger myoma pseudocapsule combined with vasopressin on laparoscopic myomectomy. Fertil Steril. 2011;95(2):762–6.CrossRefPubMed
26.
Song T, Kim MK, Kim ML, Jung YW, Yun BS, Seong SJ. Use of vasopressin vs epinephrine to reduce haemorrhage during myomectomy: a randomized controlled trial. Eur J Obstet Gynecol Reprod Biol. 2015;195:177–81.CrossRefPubMed
27.
Frederick S, Frederick J, Fletcher H, Reid M, Hardie M, Gardner W. A trial comparing the use of rectal misoprostol plus perivascular vasopressin with perivascular vasopressin alone to decrease myometrial bleeding at the time of abdominal myomectomy. Fertil Steril. 2013;100(4):1044–9.CrossRefPubMed
28.
Cohen SL, Senapati S, Gargiulo AR, Srouji SS, Tu FF, Solnik J, et al. Dilute versus concentrated vasopressin administration during laparoscopic myomectomy: a randomised controlled trial. BJOG. 2017;124(2):262–8.
29.
Deschamps A, Krishnamurthy S. Absence of pulse and blood pressure following vasopressin injection for myomectomy. Can J Anaesth. 2005;52. United States:552–3.CrossRefPubMed
30.
Butala BP, Shah VR, Parikh BK, Jayaprakash J, Kalo J. Bradycardia and severe vasospasm caused by intramyometrial injection of vasopressin during myomectomy. Saudi J Anaesth. 2014;8(3):396–8.CrossRefPubMedPubMedCentral
31.
Hobo R, Netsu S, Koyasu Y, Tsutsumi O. Bradycardia and cardiac arrest caused by intramyometrial injection of vasopressin during a laparoscopically assisted myomectomy. Obstet Gynecol. 2009;113(2 Pt 2):484–6.CrossRefPubMed
32.
Taylor A, Magos A. Reducing blood loss at open myomectomy using triple tourniquet: a randomised controlled trial. BJOG. 2006;113. England:618–9.CrossRefPubMed
33.
Vercellino G, Erdemoglu E, Joe A, Hopfenmueller W, Holthaus B, Kohler C, et al. Laparoscopic temporary clipping of uterine artery during laparoscopic myomectomy. Arch Gynecol Obstet. 2012;286(5):1181–6.CrossRefPubMed
34.
Dubuisson J, Ramyead L, Streuli I. The role of preventive uterine artery occlusion during laparoscopic myomectomy: a review of the literature. Arch Gynecol Obstet. 2015;291(4):737–43.CrossRefPubMed
35.
Wang D, Wang L, Wang Y, Lin X. The efficiency and safety of tranexamic acid for reducing blood loss in open myomectomy: a meta-analysis of randomized controlled trials. Medicine (Baltimore). 2017;96(23):e7072.CrossRef
36.
Shaaban MM, Ahmed MR, Farhan RE, Dardeer HH. Efficacy of tranexamic acid on myomectomy-associated blood loss in patients with multiple myomas: a randomized controlled clinical trial. Reprod Sci. 2016;23(7):908–12.CrossRefPubMed
37.
•• Kongnyuy EJ, Wiysonge CS. Interventions to reduce haemorrhage during myomectomy for fibroids. Cochrane Database Syst Rev. 2014;(8):CD005355. https://​doi.​org/​10.​1002/​14651858.​CD005355.​pub5. This Cochrane review update included 18 trials and determined that uterotonics, vasoconstrictors, hemostatic agents, tranexamic acid, ascorbic acid, and the use of tourniquets likely reduce blood loss in myomectomy.
38.
Caglar GS, Tasci Y, Kayikcioglu F, Haberal A. Intravenous tranexamic acid use in myomectomy: a prospective randomized double-blind placebo controlled study. Eur J Obstet Gynecol Reprod Biol. 2008;137(2):227–31.CrossRefPubMed
39.
Ngichabe S, Obura T, Stones W. Intravenous tranexamic acid as an adjunct haemostat to ornipressin during open myomectomy. A randomized double blind placebo controlled trial. Ann Surg Innov Res. 2015;9:10.CrossRefPubMedPubMedCentral
40.
Kalogiannidis I, Xiromeritis P, Prapas N, Prapas Y. Intravaginal misoprostol reduces intraoperative blood loss in minimally invasive myomectomy: a randomized clinical trial. Clin Exp Obstet Gynecol. 2011;38(1):46–9.PubMed
41.
Celik H, Sapmaz E. Use of a single preoperative dose of misoprostol is efficacious for patients who undergo abdominal myomectomy. Fertil Steril. 2003;79(5):1207–10.CrossRefPubMed
42.
Shokeir T, Shalaby H, Nabil H, Barakat R. Reducing blood loss at abdominal myomectomy with preoperative use of dinoprostone intravaginal suppository: a randomized placebo-controlled pilot study. Eur J Obstet Gynecol Reprod Biol. 2013;166(1):61–4.CrossRefPubMed
43.
Leone Roberti Maggiore U, Alessandri F, Ferrero S. Tachosil application after laparoscopic myomectomy: a prospective randomized trial [Applicazione di Tachosil dopo miomectomia laparoscopica: studio prospettico randomizzato]. Ital J Gynaecol Obstet. 2011;23(4):147–54.
44.
Raga F, Sanz-Cortes M, Bonilla F, Casan EM, Bonilla-Musoles F. Reducing blood loss at myomectomy with use of a gelatin-thrombin matrix hemostatic sealant. Fertil Steril. 2009;92(1):356–60.CrossRefPubMed
45.
Druzijanic N, Pogorelic Z, Perko Z, Mrklic I, Tomic S. Comparison of lateral thermal damage of the human peritoneum using monopolar diathermy, Harmonic scalpel and LigaSure. Can J Surg. 2012;55(5):317–21.CrossRefPubMedPubMedCentral
46.
Litta P, Fantinato S, Calonaci F, Cosmi E, Filippeschi M, Zerbetto I, et al. A randomized controlled study comparing harmonic versus electrosurgery in laparoscopic myomectomy. Fertil Steril. 2010;94(5):1882–6.CrossRefPubMed
47.
• Zhang Y, Ma D, Li X, Zhang Q. Role of barbed sutures in repairing uterine wall defects in laparoscopic myomectomy: a systemic review and meta-analysis. J Minim Invasive Gynecol. 2016;23(5):684–91. This systematic review included 7 studies demonstrating decreased suture time, operative time, blood loss, and hemoglobin drop for surgeries with barbed suture compared to conventional sutures. CrossRefPubMed
48.
• Naval S, Naval R, Rane J. Tips for safe laparoscopic multiple myomectomy. J Minim Invasive Gynecol. 2017;24(2):193. This illustrative video article demonstrates a number of intraoperative techniques to achieve success for laparoscopic myomectomy in difficult cases. CrossRefPubMed
49.
Wong AS, Cheung CW, Yeung SW, Fan HL, Leung TY, Sahota DS. Transcervical intralesional vasopressin injection compared with placebo in hysteroscopic myomectomy: a randomized controlled trial. Obstet Gynecol. 2014;124(5):897–903.CrossRefPubMed
50.
Holloran-Schwartz MB, Harrison K, Gimpelson R. Direct injection of vasopressin during hysteroscopic myomectomy: a case report. J Reprod Med. 2014;59(11–12):614–6.PubMed
51.
Phillips DR, Nathanson HG, Milim SJ, Haselkorn JS, Khapra A, Ross PL. The effect of dilute vasopressin solution on blood loss during operative hysteroscopy: a randomized controlled trial. Obstet Gynecol. 1996;88(5):761–6.CrossRefPubMed
Metadaten
Titel
Hemostasis Techniques in Myomectomies
verfasst von
Kelly Wright
Michelle Louie
Matthew Siedhoff
Publikationsdatum
21.04.2018
Verlag
Springer US
Erschienen in
Current Obstetrics and Gynecology Reports / Ausgabe 2/2018
Elektronische ISSN: 2161-3303
DOI
https://doi.org/10.1007/s13669-018-0236-4

Weitere Artikel der Ausgabe 2/2018

Current Obstetrics and Gynecology Reports 2/2018 Zur Ausgabe

Uterine Fibroids (N Narvekar, Section Editor)

New Horizons in Fibroid Management

Minimally Invasive Gynecologic Surgery (A Yunker, Section Editor)

Endometrial Ablation—Current Evidence for Patient Optimization and Long-Term Outcomes

Uterine Fibroids (N Narvekar, Section Editor)

The Life Cycle of the Uterine Fibroid Myocyte

Minimally Invasive Gynecologic Surgery (A Yunker, Section Editor)

The Loss of Vaginal Hysterectomy

Uterine Fibroids (N Narvekar, Section Editor)

Management of Fibroids in Resource-Limited Settings

Urogynecology and Reconstructive Pelvic Surgery (S Vitale, Section Editor)

Female Voiding Dysfunction: a Practical Approach to Diagnosis and Treatment

Neu im Fachgebiet Gynäkologie und Geburtshilfe

Hirsutismus bei PCOS: Laser- und Lichttherapien helfen

26.04.2024 Hirsutismus Nachrichten

Laser- und Lichtbehandlungen können bei Frauen mit polyzystischem Ovarialsyndrom (PCOS) den übermäßigen Haarwuchs verringern und das Wohlbefinden verbessern – bei alleiniger Anwendung oder in Kombination mit Medikamenten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

23.04.2024 Medikamente in Schwangerschaft und Stillzeit Nachrichten

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

23.04.2024 Depression antepartal oder postpartal Nachrichten

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

Bei RSV-Impfung vor 60. Lebensjahr über Off-Label-Gebrauch aufklären!

22.04.2024 DGIM 2024 Kongressbericht

Durch die Häufung nach der COVID-19-Pandemie sind Infektionen mit dem Respiratorischen Synzytial-Virus (RSV) in den Fokus gerückt. Fachgesellschaften empfehlen eine Impfung inzwischen nicht nur für Säuglinge und Kleinkinder.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.

Newsletter bestellen
Bildnachweise